68Ga-BNU-PSMA

N/A

Report date: 2025/11/24 17:27:29

NME

Base Information

Drug Name68Ga-BNU-PSMA

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[5]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsPositron-emission tomography enhancersIonising radiation emitters

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsNeoplasm MetastasisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesFirst Affiliated Hospital Of Fujian Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFirst Affiliated Hospital Of Fujian Medical University

Active IndicationsN/A

Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A